$60 Degrees Pharmaceuticals (SXTP.US)$Reuters· 3 mins ago 60 Degrees Pharmaceuticals Enrolls First Patient in Tafenoquine Expanded Access Clinical Study for Persistent (B. Microti) Babesiosis
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more